Page last updated: 2024-09-05

lasofoxifene and Ovarian Neoplasms

lasofoxifene has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Colgan, T; Cummings, S; Goldstein, SR; Johnson, M; Krpan, D; Neven, P; Proulx, J; Runowicz, CD; Sriram, U; Thompson, D; Thompson, J	1

Trials

1 trial(s) available for lasofoxifene and Ovarian Neoplasms

Article	Year
Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) trial: 5-year gynecological outcomes. Menopause (New York, N.Y.), 2011, Volume: 18, Issue:1 Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Ovarian Cysts; Ovarian Neoplasms; Polyps; Postmenopause; Proportional Hazards Models; Pyrrolidines; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Ultrasonography; Urinary Incontinence; Uterine Diseases; Uterus	2011

Article

Year

Postmenopausal Evaluation and Risk Reduction With Lasofoxifene (PEARL) trial: 5-year gynecological outcomes.

Menopause (New York, N.Y.), 2011, Volume: 18, Issue:1

Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Ovarian Cysts; Ovarian Neoplasms; Polyps; Postmenopause; Proportional Hazards Models; Pyrrolidines; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Ultrasonography; Urinary Incontinence; Uterine Diseases; Uterus

2011